Maria-Ecaterina Olariu, Alexandru Burlacu, Crischentian Brinza, Adrian Iftene
{"title":"Large language models for ESC guideline interpretation: a targeted review of accuracy and applicability.","authors":"Maria-Ecaterina Olariu, Alexandru Burlacu, Crischentian Brinza, Adrian Iftene","doi":"10.1080/14796678.2025.2573566","DOIUrl":null,"url":null,"abstract":"<p><p>The European Society of Cardiology (ESC) guidelines provide detailed, evidence-based recommendations for managing cardiovascular diseases. However, their complexity and frequent updates can make them challenging to apply consistently in clinical settings. Artificial intelligence (AI), particularly large language models (LLMs), offers a novel solution by assisting in the interpretation and application of these guidelines more effectively. A narrative review was conducted to assess the role of large language models (LLMs) and related artificial intelligence (AI) systems in supporting the interpretation of ESC guidelines. From 102 records screened, seven studies met the inclusion criteria. Clinical Decision Support Systems (CDSSs) built on ESC guidelines demonstrated improvements in diagnostic accuracy and standardization. Comparative studies revealed that large language models (LLMs), including ChatGPT-4, showed high concordance with expert clinical decisions (up to 86% accuracy for acute coronary syndrome-related questions). Emerging tools, such as MedDoc-Bot, have highlighted the feasibility of direct ESC guideline interpretation by LLMs. LLMs show promise in enhancing clinician understanding and application of ESC guidelines. Although performance is encouraging, further validation and thoughtful integration into clinical practice are necessary to maximize their utility and safety.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"1-8"},"PeriodicalIF":1.0000,"publicationDate":"2025-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/14796678.2025.2573566","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
The European Society of Cardiology (ESC) guidelines provide detailed, evidence-based recommendations for managing cardiovascular diseases. However, their complexity and frequent updates can make them challenging to apply consistently in clinical settings. Artificial intelligence (AI), particularly large language models (LLMs), offers a novel solution by assisting in the interpretation and application of these guidelines more effectively. A narrative review was conducted to assess the role of large language models (LLMs) and related artificial intelligence (AI) systems in supporting the interpretation of ESC guidelines. From 102 records screened, seven studies met the inclusion criteria. Clinical Decision Support Systems (CDSSs) built on ESC guidelines demonstrated improvements in diagnostic accuracy and standardization. Comparative studies revealed that large language models (LLMs), including ChatGPT-4, showed high concordance with expert clinical decisions (up to 86% accuracy for acute coronary syndrome-related questions). Emerging tools, such as MedDoc-Bot, have highlighted the feasibility of direct ESC guideline interpretation by LLMs. LLMs show promise in enhancing clinician understanding and application of ESC guidelines. Although performance is encouraging, further validation and thoughtful integration into clinical practice are necessary to maximize their utility and safety.
期刊介绍:
Research advances have contributed to improved outcomes across all specialties, but the rate of advancement in cardiology has been exceptional. Concurrently, the population of patients with cardiac conditions continues to grow and greater public awareness has increased patients" expectations of new drugs and devices. Future Cardiology (ISSN 1479-6678) reflects this new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy. Coverage will also reflect the major technological advances in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modeling and information management issues.